Skip to content
BidBenchmark

Contract award

EXELAN PHARMACEUTICALS INC

LENALIDOMIDE/REVLIMID DOSE
PIID
36C25226P0110
Award key
CONT_AWD_36C25226P0110_3600_-NONE-_-NONE-
Recipient UEI
FYZXNHSQTMG8
Source as of
Current award value
$1,400,4353
Obligated to date
$1,400,4352
Potential with options
$1,400,4353
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
Boca Raton, Florida
Set-aside
No set-aside used
Pricing
Firm Fixed Price
Competition
Full and Open Competition2 offers received
Period of performance
Dec 15, 2025Dec 14, 2026Through Dec 14, 2026 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Dec 11, 2025Initial award$2,000,000.00$1,400,434.66
P00001Aug 18, 2026M-$599,565.34$1,400,434.66

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 20, 2026usaspending_contract_csv@2026.08.232caa5c24e6d
contractor_idUSAspending.govAug 20, 2026usaspending_contract_csv@2026.08.232caa5c24e6d
current_award_valueUSAspending.govAug 20, 2026usaspending_contract_csv@2026.08.232caa5c24e6d
naics_codeUSAspending.govAug 20, 2026usaspending_contract_csv@2026.08.232caa5c24e6d
potential_award_valueUSAspending.govAug 20, 2026usaspending_contract_csv@2026.08.232caa5c24e6d
psc_codeUSAspending.govAug 20, 2026usaspending_contract_csv@2026.08.232caa5c24e6d
total_obligatedUSAspending.govAug 20, 2026usaspending_contract_csv@2026.08.232caa5c24e6d

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 2 transaction records parsed from USAspending.gov, retrieved Aug 20, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36C25226P0110 — EXELAN PHARMACEUTICALS INC · BidBenchmark